View in EDS

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.

Saved in:
Bibliographic Details
Title: Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.
Authors: Wang HT; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, 406040, Taiwan., Yu YL; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, 406040, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan.; Center for Molecular Medicine, China Medical University Hospital, Taichung, 404327, Taiwan.; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, 413305, Taiwan., Lo WJ; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Lin MC; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Chu CL; Cancer Center, China Medical University Hospital, Taichung, 404327, Taiwan., Chen CY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Wang ST; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Chiu CF; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.; Cancer Center, China Medical University Hospital, Taichung, 404327, Taiwan.; College of Medicine, School of Medicine, China Medical University, Taichung, 406404, Taiwan., Bai EJ; Bachelor of Science in Kinesiology, Exercise Science, The University of Texas at Austin, Austin, TX, 78712, USA., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan. lybai6@gmail.com.; College of Medicine, School of Medicine, China Medical University, Taichung, 406404, Taiwan. lybai6@gmail.com.
Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Feb; Vol. 31 (2), pp. 281-291. Date of Electronic Publication: 2025 Dec 10.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41369826
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+HT%22">Wang HT</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, 406040, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yu+YL%22">Yu YL</searchLink>; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, 406040, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan.; Center for Molecular Medicine, China Medical University Hospital, Taichung, 404327, Taiwan.; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, 413305, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lo+WJ%22">Lo WJ</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+MC%22">Lin MC</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chu+CL%22">Chu CL</searchLink>; Cancer Center, China Medical University Hospital, Taichung, 404327, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+CY%22">Chen CY</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+ST%22">Wang ST</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chiu+CF%22">Chiu CF</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.; Cancer Center, China Medical University Hospital, Taichung, 404327, Taiwan.; College of Medicine, School of Medicine, China Medical University, Taichung, 406404, Taiwan.<br /><searchLink fieldCode="AU" term="%22Bai+EJ%22">Bai EJ</searchLink>; Bachelor of Science in Kinesiology, Exercise Science, The University of Texas at Austin, Austin, TX, 78712, USA.<br /><searchLink fieldCode="AU" term="%22Bai+LY%22">Bai LY</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan. lybai6@gmail.com.; College of Medicine, School of Medicine, China Medical University, Taichung, 406404, Taiwan. lybai6@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229616295%22">International journal of clinical oncology</searchLink> [Int J Clin Oncol] 2026 Feb; Vol. 31 (2), pp. 281-291. <i>Date of Electronic Publication: </i>2025 Dec 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Tokyo%22">Springer-Verlag Tokyo </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9616295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-7772 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213419625%22">13419625 </searchLink><i>NLM ISO Abbreviation: </i>Int J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41369826
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10147-025-02930-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 281
    Titles:
      – TitleFull: Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang HT
      – PersonEntity:
          Name:
            NameFull: Yu YL
      – PersonEntity:
          Name:
            NameFull: Lo WJ
      – PersonEntity:
          Name:
            NameFull: Lin MC
      – PersonEntity:
          Name:
            NameFull: Chu CL
      – PersonEntity:
          Name:
            NameFull: Chen CY
      – PersonEntity:
          Name:
            NameFull: Wang ST
      – PersonEntity:
          Name:
            NameFull: Chiu CF
      – PersonEntity:
          Name:
            NameFull: Bai EJ
      – PersonEntity:
          Name:
            NameFull: Bai LY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1437-7772
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International journal of clinical oncology
              Type: main
ResultId 1